Share issue open! Injeq improves patient safety with a smart needle

Injeq Oyj is a Finnish MedTech company, that offers unique smart needles for demanding patient injections, such as lumbar punctures. Injeq uses patented technology, and currently, there are no competing products on the market.

“Our technology has the potential to transform the way that lumbar punctures are conducted for adults, newborns and people with difficult anatomy. Furthermore, Injeq intends to bring equal, affordable healthcare to all including patients in developing regions of the world”, says Timo Hänninen, Injeq’s CEO.

Key investment highlights:

☆ Complete and licensed product – Injeq is a Finnish medical technology company currently in the commercial expansion phase having received a CE certification for its first product, the IQ-Tip®, in late 2021.

☆ Solution to a predominant problem – The IQ-Tip® is a new, safe, and more efficient alternative to the current lumbar puncture methods bringing real added value to doctors and patients all over the world.

☆ Solid growth strategy with first steps already implemented – Injeq is currently scaling in the European market after which it aims to expand its distributor network and operations to new markets. Injeq currently has distributor agreements in 14 European countries and additionally in Kuwait and Taiwan.

☆ Scaling business model currently in ramp-up phase – Injeq’s technology is scalable and can also be expanded to cover other application areas than lumbar punctures. Injeq has begun the first deliveries of the IQ-Tip®.

☆ Capable and highly experienced management – Injeq’s highly capable and experienced management and board of directors are committed to developing the Company.

Learn more about the investment opportunity
in English

Tiedote osakkeenomistajille / Notice to shareholders

Read more »

News release on April 12, 2024

The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »

Information to shareholders, March 22nd, 2024

Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »

Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen

Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »

New distributor agreement with “GENFAX SRL”

We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »